Shearman & Sterling represented GMS Ventures and Investments in the transaction. Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an...
Outlook Therapeutics’ $159 Million Private Placement
Kinder Morgan’s $2.25 Billion Senior Notes Offering
Bracewell represented Kinder Morgan, Inc. in the offering, and Shearman & Sterling represented the underwriters. Kinder Morgan, Inc. (NYSE: KMI) announced its $2.25 billion Notes offering, consisting...
Quantum-Si’s $75 Million ATM Equity Offering Program
Mintz Levin represented Quantum-Si, and Shearman & Sterling represented the sales agent in the offering. Quantum-Si Incorporated announced the commencement of an at-the-market equity offering program...
Lowe’s Companies’ $3 Billion Investment Grade Debt Offering
Cleary Gottlieb and Moore & Van Allen advised Lowe’s on the offering, while Shearman & Sterling advised the representatives of the underwriters involved. Lowe’s Companies, Inc. announced...
SilverBox Corp III’s $138 Million Initial Public Offering
Shearman & Sterling advised Credit Suisse as sole book-running manager on the transaction. SilverBox Corp III, a special-purpose acquisition company, executed its IPO of 13.80 million units...
Lowe’s $4.75 Billion Notes Offering
Cleary Gottlieb Steen & Hamilton represented Lowe’s Companies in the transaction. Shearman & Sterling represented Barclays Capital, Goldman Sachs, U.S. Bancorp Investments and Wells Fargo Securities...